BioStem Technologies, Inc. (BSEM)

Market Cap	141.15M
Revenue (ttm)	210.49M
Net Income (ttm)	15.85M
Shares Out	16.70M
EPS (ttm)	0.82
PE Ratio	10.32
Forward PE	4.18
Dividend	n/a
Ex-Dividend Date	n/a

Volume	21,940
Average Volume	44,428
Open	8.71
Previous Close	8.30
Day's Range	7.70 - 8.97
52-Week Range	6.77 - 28.26
Beta	1.22
RSI	36.52
Earnings Date	Apr 1, 2025

About BioStem Technologies

BioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases. The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding supplies; and develops and markets nutraceutical pr...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2006
• Employees: 33
• Stock Exchange: OTCMKTS
• Ticker Symbol: BSEM

Financial Performance

In 2023, BioStem Technologies's revenue was $16.69 million, an increase of 142.69% compared to the previous year's $6.88 million. Losses were -$8.48 million, 17.9% more than in 2022.